Leland Gershell - Oppenheimer Analyst Performance This page shows the methodology used to calculate Leland Gershell's recommendation performance. Listed below are links to the research notes issued, the price targets issued by the analyst, and the stock's actual price 12 months from the date the research note was issued. These rankings are based on research reports from . Rankings are updated daily. MarketBeat Analyst Ranking: Subscribe to MarketBeat All Access for the recommendation accuracy ratingAverage 12-Month ROI of Buy and Strong Buy Recommendations: ???% Export to Excel CompanyReport DateReport Date Price12-MonthPrice TargetRating12-MonthActual Price12-MonthROIDetailsVRDNViridian Therapeutics8/7/2025$16.81$32.00Outperform???%???%SLNOSoleno Therapeutics8/7/2025$80.36$110.00Outperform???%???%BBIOBridgeBio Pharma8/6/2025$49.21$61.00Outperform???%???%ALNYAlnylam Pharmaceuticals8/4/2025$401.80$490.00Outperform???%???%LXEOLexeo Therapeutics7/31/2025$4.65$20.00Outperform???%???%RYTMRhythm Pharmaceuticals7/10/2025$88.42$110.00Outperform???%???%BBIOBridgeBio Pharma7/9/2025$43.19$60.00Outperform???%???%CAPRCapricor Therapeutics6/23/2025$7.15$22.00Outperform???%???%URGNUrogen Pharma6/13/2025$13.49$31.00Buy???%???%ASNDAscendis Pharma A/S6/13/2025$172.66$224.00Outperform???%???%CLYMClimb Bio6/6/2025$1.24$10.00Outperform???%???%URGNUrogen Pharma6/3/2025$4.96$10.00Outperform???%???%XERSXeris Biopharma5/9/2025$5.07$7.00Outperform???%???%ARGXargenex5/9/2025$554.89$708.00Outperform???%???%QNCXQuince Therapeutics3/24/2025$1.38$10.00Outperform???%???%TRVITrevi Therapeutics3/11/2025$5.87$20.00Outperform???%???%ARGXargenex2/28/2025$619.04$704.00Outperform???%???%BMRNBioMarin Pharmaceutical2/24/2025$68.25$98.00Outperform???%???%HZNPHorizon Therapeutics Public7/8/2022$83.61$140.00Buy???%???%AVTXAvalo Therapeutics1/7/2022$2,995.20$14,400.00Buy???%???%CRXTQClarus Therapeutics9/20/2021$8.81$12.00Outperform???%???%VERUVeru8/27/2021$9.09$26.00Buy???%???%XLRNAcceleron Pharma11/16/2020$114.03$131.00Outperform???%???%ALNYAlnylam Pharmaceuticals9/30/2020$146.73$156.00Hold???%???%VERUVeru9/21/2020$2.87$9.00Buy???%???%CRBPCorbus Pharmaceuticals9/8/2020$2.23Market Perform???%???%VBIVVBI Vaccines8/27/2020$64.20$160.00Buy???%???%BMRNBioMarin Pharmaceutical8/20/2020$74.85$88.00???%???%OTLKOncobiologics8/18/2020$28.20$160.00Outperform???%???%VERUVeru8/14/2020$3.03$9.00Buy???%???%ALNYAlnylam Pharmaceuticals8/11/2020$138.57$156.00Market Perform???%???%EVFMEvofem Biosciences8/10/2020$5,493.75$46,875.00Outperform???%???%ADMAADMA Biologics8/6/2020$2.86$6.00Buy???%???%BMRNBioMarin Pharmaceutical8/5/2020$119.83$116.00Hold???%???%MISTMilestone Pharmaceuticals7/29/2020$8.01$18.00Outperform???%???%ACSTAcasti Pharma6/30/2020$22.76$336.00Buy???%???%CRBPCorbus Pharmaceuticals6/29/2020$7.91$28.00Buy???%???%VBIVVBI Vaccines6/23/2020$52.40$160.00Outperform???%???%CRBPCorbus Pharmaceuticals6/19/2020$7.97$28.00Buy???%???%AMRNAmarin6/3/2020$6.83Hold???%???%OTLKOncobiologics6/3/2020$23.20$180.00Buy???%???%EVFMEvofem Biosciences5/27/2020$10,856.25$46,875.00Outperform???%???%EVFMEvofem Biosciences5/25/2020$9,356.25$43,125.00Buy???%???%ASNDAscendis Pharma A/S5/20/2020$143.19$208.00Outperform???%???%VERUVeru5/14/2020$3.53$9.00Outperform???%???%MISTMilestone Pharmaceuticals5/14/2020$3.13Hold???%???%BXRXBaudax Bio5/11/2020$60.60$280.00Outperform???%???%ALNYAlnylam Pharmaceuticals5/7/2020$145.27$162.00Outperform???%???%XFORX4 Pharmaceuticals5/7/2020$256.80$600.00Buy???%???%URGNUrogen Pharma5/7/2020$23.61$47.00Buy???%???%VBIVVBI Vaccines5/7/2020$26.60$100.00Buy???%???%ASNDAscendis Pharma A/S4/20/2020$129.00$219.00Outperform???%???%ALNYAlnylam Pharmaceuticals4/13/2020$119.01$140.00Buy???%???%AMRNAmarin3/31/2020$13.58Market Perform???%???%MISTMilestone Pharmaceuticals3/24/2020$14.00Market Perform???%???%ASNDAscendis Pharma A/S3/19/2020$101.04$199.00Outperform???%???%MISTMilestone Pharmaceuticals3/6/2020$20.52$32.00Buy???%???%AMRNAmarin2/26/2020$350.00$240.00Underperform???%???%XLRNAcceleron Pharma2/11/2020$95.36$112.00Outperform???%???%XLRNAcceleron Pharma1/28/2020$80.03$79.00???%???%ACSTAcasti Pharma1/22/2020$34.57$336.00Buy???%???%AMRNAmarin1/22/2020$419.00$260.00Sell???%???%BXRXBaudax Bio1/21/2020$140.80$240.00Buy???%???%ACSTAcasti Pharma12/26/2019$122.88$336.00Buy???%???%XLRNAcceleron Pharma9/17/2019$43.10$58.00Buy???%???%REPHRecro Pharma8/9/2019$10.95$20.00Buy???%???%ADMAADMA Biologics6/25/2019$3.58$14.00Buy???%???%VBIVVBI Vaccines6/19/2019$19.40$100.00Buy???%???%EVFMEvofem Biosciences4/12/2019$7,687.50$20,625.00Outperform???%???%REPHRecro Pharma4/4/2019$8.34$15.00Outperform???%???%ADMAADMA Biologics4/2/2019$4.07$16.00Outperform???%???%REPHRecro Pharma3/25/2019$6.41$9.00Outperform???%???%URGNUrogen Pharma3/19/2019$38.13Buy???%???%MEIPMEI Pharma3/19/2019$3.07Buy???%???%URGNUrogen Pharma2/28/2019$38.48$70.00Buy???%???%EPZMEpizyme2/27/2019$13.96$18.00Outperform???%???%AZRXAzurRx BioPharma2/26/2019$21.10$80.00Buy???%???%VBIVVBI Vaccines2/26/2019$36.80$180.00Buy???%???%BMRNBioMarin Pharmaceutical2/22/2019$88.09$81.00???%???%AZRXAzurRx BioPharma2/20/2019$20.10$60.00Buy???%???%REPHRecro Pharma2/20/2019$8.59$18.00Buy???%???%VCNXVaccinex1/16/2019$1,119.30$4,620.00Buy???%???%BMRNBioMarin Pharmaceutical1/8/2019$92.30$92.00Hold???%???%EPZMEpizyme1/4/2019$7.94$27.00Buy???%???%ADMAADMA Biologics12/20/2018$2.40$13.00Buy ADMA???%???%EVFMEvofem Biosciences12/17/2018$6,636.56$16,875.00Buy???%???%BMRNBioMarin Pharmaceutical12/13/2018$93.89$92.00Hold???%???%AZRXAzurRx BioPharma12/12/2018$17.60$60.00Buy???%???%ACRXAcelRx Pharmaceuticals12/11/2018$3.15Hold???%???%CPRXCatalyst Pharmaceuticals11/29/2018$2.78$6.00Buy???%???%AZRXAzurRx BioPharma11/19/2018$21.50$60.00Buy???%???%EVFMEvofem Biosciences11/16/2018$6,318.75$16,875.00Buy???%???%ATXIAvenue Therapeutics11/15/2018$5,467.50$11,250.00Buy???%???%VCNXVaccinex11/13/2018$1,369.20$4,620.00Buy???%???%URGNUrogen Pharma11/13/2018$45.70$75.00Buy???%???%ADMAADMA Biologics11/12/2018$5.16$13.00Buy???%???%REPHRecro Pharma11/8/2018$7.29$18.00Buy???%???%CPRXCatalyst Pharmaceuticals11/8/2018$3.08$6.00Buy???%???%EVFMEvofem Biosciences11/7/2018$6,675.00$16,875.00Buy???%???%AZRXAzurRx BioPharma11/1/2018$23.60$60.00Buy???%???%ADMAADMA Biologics10/17/2018$5.37$13.00Buy???%???%AZRXAzurRx BioPharma10/17/2018$25.00$60.00Outperform???%???%CPRXCatalyst Pharmaceuticals10/16/2018$3.47$6.00Buy???%???%ACRXAcelRx Pharmaceuticals10/15/2018$3.98Hold???%???%ACRXAcelRx Pharmaceuticals10/9/2018$2.74Hold???%???%ADMAADMA Biologics10/2/2018$5.85$13.00Buy???%???%REPHRecro Pharma9/5/2018$8.07$18.00Buy???%???%ADMAADMA Biologics9/5/2018$6.81$13.00Buy???%???%VCNXVaccinex9/4/2018$2,097.90$4,620.00Buy???%???%ATXIAvenue Therapeutics8/15/2018$4,275.00$9,000.00Buy???%???%URGNUrogen Pharma8/14/2018$44.56$75.00Buy???%???%ADMAADMA Biologics8/13/2018$6.17$13.00Buy???%???%CPRXCatalyst Pharmaceuticals8/9/2018$2.93$6.00Buy???%???%REPHRecro Pharma8/8/2018$5.66$18.00Buy???%???%ADMAADMA Biologics8/5/2018$6.23$13.00Buy???%???%ACRXAcelRx Pharmaceuticals8/3/2018$2.60Hold???%???%EVFMEvofem Biosciences8/3/2018$3,731.25$16,875.00Buy???%???%ACRXAcelRx Pharmaceuticals7/12/2018$2.95Hold???%???%CPRXCatalyst Pharmaceuticals7/12/2018$3.20$6.00Buy???%???%ATXIAvenue Therapeutics7/12/2018$4,151.25$9,000.00Buy???%???%ADMAADMA Biologics7/12/2018$4.53$13.00Buy???%???%REPHRecro Pharma5/25/2018$5.63$18.00Buy???%???%URGNUrogen Pharma5/22/2018$62.86$75.00Buy???%???%URGNUrogen Pharma5/15/2018$60.14$75.00Buy???%???% Return to Analyst Rankings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
